Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19

Cakakinumab: no funcional en COVID-19

🆕💥💥 (CAN-COVID) RCT @JAMA_current Effect of anti–interleukin-1β antibody Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe #COVID19 https://t.co/irwJG3Tm8g https://t.co/EbTFlZIIBp

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

#RT @ctisus: RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantly increase the likelihood of survival without invasive mechanical ventilation https://t.co/qTycfyT8Et

Although closely related to IL-6 axis, IL-1RA failed to improve outcomes in patients with severe #COVID19

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

RT @JAMA_current: Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantl…

Among patients hospitalized with severe #COVID19, treatment with canakinumab, compared with placebo, did not significantly increase the likelihood of survival without invasive mechanical ventilation https://t.co/O6Zikfq9ag